fynark

Global

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

04 DE AGO DE 2026Por Administrador FynarkFonte: CNBC
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

Fonte original: https://www.cnbc.com/2026/08/04/pfizer-pfe-earnings-q2-2026.html

Notícias relacionadas